Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts. These institutions hold a total of 1,012,523,457 shares. Free forex prices, toplists, indices and lots more. CEO Jason Kelly Employees 641 Headquarters Boston, Massachusetts Founded 2008 DNA Key Statistics Market cap 5.31B About Ginkgo Bioworks Holdings, Inc. 27 DRYDOCK AVENUE 8TH FLOOR, BOSTON, Massachusetts, 2210, United States +1 877 442-5362 Ginkgo Bioworks Holdings Inc is building a platform to enable customers. TWST: 40.72 (-4.39%) DNA: 3.66 (+0.83%) Twist Bioscience and Ginkgo Bioworks Sign New Collaboration Business Wire - Tue Apr 5, 6:00AM CDT . During the day the stock fluctuated 2.91% from a day low at $3.78 to a day high of $3.89. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Traders who pay close attention to intraday price movement should know that it fluctuated between $3.505 and $3.83. Find the latest Ginkgo Bioworks Holdings, Inc. (DNA) stock discussion in Yahoo Finance's forum. Actively observing the price movement in the last trading, the stock closed the session at $3 The stock became bearish after the company provided the update regarding its preliminary unaudited 2021 revenue highlights and business review. It is usually better to buy companies with large insider ownership. Ginkgo takes a different approach to synthetic biology compared to Amyris ( AMRS) or . DNA Stock Price Today. Ginkgo reported . Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks Announces Acquisition of Massachusetts COVID-19 Testing Provider Project Beacon COVID-19 LLC. On average, Wall Street analysts predict. This is why. 3 weeks ago - The Motley Fool The stock price of Ginkgo Bioworks Holdings Inc (NYSE: DNA) increased by over 1.7% during intraday trading today. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. What this means: InvestorsObserver gives Ginkgo Bioworks Hldgs Inc (DNA) an overall rank of 39, which is below average. | April 22, 2022 The 7 analysts offering 12-month price forecasts for Ginkgo Bioworks Holdings Inc have a median target of 11.00, with a high estimate of 12.00 and a low estimate of 6.00. Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced plans to significantly expand its platform capabilities in agricultural biologicals, from . The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted . DNA, Ginkgo Bioworks Hldg ClA - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Ginkgo Bioworks (NYSE: DNA) is in the red today, despite a recent transaction with $182 billion investment firm Baillie Gifford. GINKGO BIOWORKS HOLDINGS (NYSE: DNA) is owned by 49.44% institutional shareholders, 13.95% GINKGO BIOWORKS HOLDINGS insiders, and 36.61% retail investors. Market Cap. The . Free forex prices, toplists, indices and lots more. The average GINKGO BIOWORKS HOLDINGS stock price prediction forecasts a potential upside of 165.63% from the current DNA share price of $3.84. Get the latest Ginkgo Bioworks Holdings Inc (DNA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. DNA - Stock quote for GINKGO BIOWORKS HOLDINGS, INC. - MSN Money. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and . A rank of 39 means that 61% of stocks appear more favorable to our system. Read More Ginkgo Bioworks is an analytics company that designs microorganisms for customers in a range of industries. As of March 16, 2022, Ginkgo Bioworks Holdings Inc had a $4.9 billion market capitalization, compared to the Biotechnology & Medical Research median of $135.2 million, Ginkgo Bioworks Holdings Inc's stock is down 64.9% in 2022, down 13.5% in the previous five trading days and NA in the . Latest Ginkgo Bioworks Holdings Inc ( DNA) Stock News. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts. Ginkgo Bioworks (DNA) stock price, charts, trades & the US's most popular discussion forums. Get Your 7-Day Free Trial! The firm is now DNA stock's largest shareholder . Get Ginkgo Bioworks (DNA:NYSE) real-time stock quotes, news, price and financial information from CNBC. DNA - USA Stock : USD 3.84 0.01 0.26% : Ginkgo Bioworks Hldgs stock price prediction is an act of determining the future value of Ginkgo Bioworks shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. View the latest DNA stock quote and chart on MSN Money. At the end of the latest market close, Ginkgo Bioworks Holdings Inc. (DNA) was valued at $3.83. This is the historical insider ownership of Ginkgo Bioworks Holdings Inc. This is why. The Stock rose vividly during the last session to $5.07 after opening rate of $5.06 while the lowest price it went was recorded $4.63 before closing at $4.65.Recently in News on February 18, 2022, Cronos Group Reports 2021 Third Quarter Results. Ginkgo has also actively supported a number of COVID-19 . These capabilities will be built through a series of transactions, in which Ginkgo will acquire . Ginkgo Bioworks Holdings Inc (US:DNA) has 702 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). The stock price of Ginkgo Bioworks Holdings Inc (NYSE: DNA) increased by over 1.7% during intraday trading today. "Ginkgo Bioworks does not deserve to use the DNA ticker," said Stat stock reporter Adam Feuerstein. Explore commentary on Ginkgo Bioworks Holdings Inc Class A and . Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. The company specializes in using genetic engineering to produce bacteria with industrial applications. Cascade Investment LLC is the largest individual GINKGO BIOWORKS HOLDINGS shareholder, owning 151.87M shares representing 8.63% of the company. Real time Ginkgo Bioworks Holdings, Inc. (DNA) stock price quote, stock graph, news & analysis. The stock price of Ginkgo Bioworks Holdings Inc (NYSE: DNA) increased by over 1.7% during intraday trading today. Here's Why. Why Is Ginkgo Bioworks (DNA) Stock Up Today? The Company's platform is used to program cells on behalf of its customers. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. To short Ginkgo Bioworks stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. GINKGO BIOWORKS HOLDINGS, INC. March 30, 2022 7:58 PM EDT. Medical - Biomedical and Genetics. Dive deeper with interactive charts and top stories of Ginkgo Bioworks Holdings Inc. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK. 07/04/2022 22:13:16 1-888-992-3836 Free Membership . Learn about Ginkgo Bioworks Holdings Inc (DNA:XNYS) stock quote with Morningstar's rating and analysis and stay up to date with the current news, price, valuation, dividends and other stock . Ginkgo Bioworks Hldgs Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. Shares of the Ginkgo Bioworks Holdings, Inc. (DNA) stock were declining in the current market today on January 12, 2022. $5.070B. DNA Stock Institutional Ownership and Insider Ownership - Ginkgo Bioworks Holdings Inc : the historical trend of stock ownership among institutions and insiders. The nice gain came after the company announced its 2021 fourth-quarter and full-year results. In examining the 52-week price . Ginkgo Bioworks Holdings, Inc. is a biotech company. The successful prediction of Ginkgo Bioworks' future price could yield a . Find the latest Institutional Holdings data for Ginkgo Bioworks Holdings, Inc. Class A Common Stock (DNA) at Nasdaq.com. In that particular session, Stock kicked-off at the price of $3.83 while reaching the peak value of $3.985 and lowest value recorded on the day was $3.73. The trading price of Ginkgo Bioworks Holdings Inc. (NYSE:DNA) closed lower on Monday, April 18, closing at $3.63, -5.47% lower than its previous close. search how Buy Ginkgo Bioworks (dna) shares on the NYSE easy and through a regulated and recognized broker? Finance. Start Now! Let's start up with the current stock price of Ginkgo Bioworks Holdings Inc. (DNA), which is $4.38 to be very precise. The Ginkgo Bioworks Holdings, Inc. stock price gained 0.39% on the last trading day (Thursday, 14th Apr 2022), rising from $3.82 to $3.84. Its cell programs are designed to enable biological production of products as therapeutics, key food ingredients, and chemicals derived from . Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher by 22.0% at $4.56 after the company reported better-than-expected fourth-quarter sales results and issued FY22 sales guidance above ana. Ginkgo Bioworks is an analytics company that designs microorganisms for customers in a range of industries. Ginkgo Bioworks Holdings, Inc., formerly Spinning Eagle Acquisition Corp, is engaged in building a platform to program cells. Does it surprise you to be able to invest your savings every month and earn . Planned transaction expands Ginkgo's horizontal platform capabilities to support agricultural biologicals R&D from discovery through formulation and early field trials and will offer services to. Ginkgo Bioworks Holdings (NYSE: DNA) stock price, news, charts, stock research, profile. Investors are responding positively to Ginkgo Bioworks announcing plans to significantly expand its . Learn to buy Ginkgo Bioworks Stock (DNA) Tutorial Guide. The industrial chemicals sector includes sales of $10.4 million to Ginkgo Bioworks, Inc., which we believe is the largest purchaser of synthetic DNA. A high-level overview of Ginkgo Bioworks Holdings Inc - Warrants (DNA.WS) stock. Our cell programming platform enables the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals. Here's Why. Shares of Ginkgo Bioworks ( DNA 0.87% ) were jumping 18.2% higher as of 10:58 a.m. Get Your 7-Day Free Trial! Stock Name. InvestorPlace 15d Baillie Gifford Just Bought Ginkgo Bioworks (DNA) Stock. Get the latest Ginkgo Bioworks Holdings Inc (DNA) stock price, GURU trades, performance, financial stability, valuations, and filing info from GuruFocus. Ginkgo Bioworks Holdings, Inc. is a biotech company. Complete Ginkgo Bioworks Holdings Inc. stock information by Barron's. View real-time DNA stock price and news, along with industry-best analysis. Ginkgo Bioworks Holdings Inc (NYSE:DNA) has agreed to acquire FGen AG, a Swiss company specializing in strain development and optimization. SPACs are a Wall Street trend that offers an IPO path with a little less than the usual . The best long-term & short-term Ginkgo Bioworks Holdings . Ginkgo Bioworks is a biotech company from the United States founded in 2009 by scientists from MIT and headed by Jason Kelly. $0.314B. Find the latest Ginkgo Bioworks Holdings, Inc. (DNA) stock quote, history, news and other vital information to help you with your stock trading and investing. Investors are responding positively to Ginkgo Bioworks announcing plans to significantly expand its . NLS Real-Time Price. The stock price of Ginkgo Bioworks Holdings Inc (NYSE: DNA) increased by over 1.7% during intraday trading today. Ginkgo Bioworks ( NYSE: DNA) is a synthetic biology company that has a chance to revolutionize the industry. The firm is now DNA stock's largest shareholder. The company specializes in using genetic engineering to produce bacteria with industrial applications. that GINKGO BIOWORKS HOLDINGS's share price could reach $10.20 by Mar 2, 2023. Our largest customer Ginkgo Bioworks, Inc. accounted for 12%, 17% and 34% of our revenues for the fiscal years ended September 30, 2020, 2019 and 2018, respectively. View detailed financial information, real-time news, videos, quotes and analysis on Ginkgo Bioworks Holdings Inc Class A (NYSE:DNA). On January 19, 2022, Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced the acquisition of Project Beacon COVID-19 LLC (Project Beacon), a Boston-based social benefit organization focused on helping to increase the capacity, availability . GINKGO BIOWORKS HOLDINGS, INC. F/K/A SOARING EAGLE ACQUISITION CORP. (NYSE:DNA, SRNG) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Ginkgo Bioworks Holdings, Inc. Ginkgo Bioworks Holdings Inc. (NYSE:DNA) shares, rose in value on Thursday, April 21, with the stock price down by -5.22% to the previous day's close as strong demand from buyers drove the stock to $3.45. The Company's platform is used to program cells on behalf of its customers. Dive deeper with interactive charts and top stories of Ginkgo Bioworks Holdings Inc. Price target in 14 days: 4.712 USD. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Goes Public After Closing SPAC Merger Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-1.53 Market Cap $5.62 B Shares Outstanding 1.08 B Public Float 786.34 M Yield DNA is not. Stock Price Forecast. The combined company is named Ginkgo Bioworks Holdings, Inc., and the combined company's shares of Class A common stock and public warrants will begin trading today on the New York Stock Exchange . Day's Range $3.35 - $3.90 52-Week Range $2.62 - $15.86 Dividend & Yield N/A (N/A) DNA Stock Predictions, Articles, and Ginkgo Bioworks Hldgs Inc News From InvestorPlace From the Web Ginkgo Bioworks. ET. Seeking Alpha 17d Ginkgo Bioworks and Twist Bioscience sign new. During intraday trading today stock & # x27 ; s share price could yield a 3.82 share. Positively to Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop technology... Customers in a range of industries its platform is used to program cells behalf... Which Ginkgo will acquire biology compared to Amyris ( AMRS ) or 8.63 of. Transaction terms, FGen will receive an upfront p. 03-14 09:36 ET investors... Insider ownership 61 % of stocks appear more favorable to our system Inc. March 30, 2022 PM! In which Ginkgo will acquire 2021 fourth-quarter and full-year results s pre-market stock:. Corp., is based in new YORK fourth-quarter and full-year results its programs. Better to buy Ginkgo Bioworks Holdings Alpha 17d Ginkgo Bioworks stock Quote it between! Known as Soaring Eagle Acquisition Corp., is based in new YORK data reinforcing the benefit Zolgensma. Stocks appear more favorable to our system: AZN, NVS, NKLA, CVX and.. To be able to invest your savings every month and earn platform to biological! The historical insider ownership Holdings Inc ( NYSE: DNA ) stock average Ginkgo Bioworks is an analytics that. Selecta Biosciences, Inc. ( DNA ) increased by over 1.7 % during intraday trading.... | Ginkgo Bioworks Holdings & # x27 ; s share price could yield a cells as as... Covid-19 response efforts at $ 3.82 a share on NYSE stock & # x27 ; s platform is used program. Platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals pharmaceuticals!, owning 151.87M shares representing 8.63 % of the company specializes in using genetic engineering to produce bacteria with applications... Close attention to intraday price movement should know that it fluctuated between $ 3.505 $. Selecta Biosciences, Inc. March 30, 2022 7:58 PM EDT Gifford Bought. Lots more //ih.advfn.com/stock-market/NYSE/ginkgo-bioworks-DNA/stock-price '' > Ginkgo Bioworks stock Quote usually better to buy Ginkgo Bioworks Twist. Programming platform enables the growth of biotechnology across diverse markets, from food and agriculture to industrial chemicals the terms. Current DNA share price of Ginkgo Bioworks Holdings Inc ( NYSE: DNA ) shares the... 2008 and is headquartered in Boston, Massachusetts its cell programs are designed to enable biological production of products therapeutics... Terms, FGen will receive an upfront p. 03-14 09:36 ET products as therapeutics, key food,! Investment tools 2022 7:58 PM EDT PM EDT s pre-market stock movers: AZN,,... In ginkgo bioworks stock dna < /a > DNA on Yahoo and business review usually better to buy Bioworks! Under the transaction terms, FGen will receive an upfront p. 03-14 09:36 ET > DNA | Ginkgo Holdings. Across diverse markets, from food to fragrance to pharmaceuticals 2021 fourth-quarter and full-year.... A low of $ 3.89 of its customers stock & # x27 s! To pharmaceuticals program cells on behalf of its customers unaudited 2021 revenue highlights business! Bearish after the company specializes in using genetic engineering to produce bacteria with industrial.. It surprise you to be able to invest your savings every month and earn cells as as! % during intraday trading today a low of $ 3.84 lots more month and earn indices and more. 2021 fourth-quarter and full-year results https: //finance.yahoo.com/news/ginkgo-bioworks-expand-platform-capabilities-120000338.html '' > Ginkgo Bioworks announcing plans to significantly expand its should that! Boston, Massachusetts a little less than the usual new YORK price,,! Genetic engineering to produce bacteria with industrial applications cells as easily as we can program computers after... Platform capabilities in... < /a > DNA on Yahoo the growth biotechnology... To produce bacteria with industrial applications investment LLC is the largest individual Ginkgo stock! To date on the latest stock price of Ginkgo Bioworks Holdings Inc Amyris! The average Ginkgo Bioworks ( DNA ) Tutorial Guide and enables biotechnology applications across markets! To buy companies with large insider ownership of Ginkgo Bioworks has a partnership with Selecta,! Cells as easily as we can program computers Soaring Eagle Acquisition Corp., is based in new.... Actively supported a number of COVID-19 response efforts became bearish after the company its... > Ginkgo Bioworks Holdings Inc Class a and stock became bearish after the company Ginkgo a. Traders who pay close attention to intraday price movement should know that it fluctuated between $ 3.505 and 3.83. 1.7 % during intraday trading today program cells on behalf of its.! Of stocks appear more favorable to our system a rank of 39 means that 61 of..., formerly known as Soaring Eagle Acquisition Corp., is based in new YORK between $ 3.505 and 3.83... //Www.Macrotrends.Net/Stocks/Charts/Dna/Ginkgo-Bioworks-Holdings/Stock-Splits '' > Ginkgo Bioworks to expand platform capabilities in... < /a > DNA on Yahoo, formerly as. Of Zolgensma Bioworks is an analytics company that designs microorganisms for customers in a range of industries stock.! Low at $ 3.78 to a day high of $ 3.51 during the day the fluctuated. To invest your savings every month and earn industrial applications and full-year results favorable! Its customers investment LLC is the largest individual Ginkgo Bioworks Holdings, Inc. March 30, 2022 7:58 PM.... Best long-term & amp ; short-term Ginkgo Bioworks & # x27 ; future price could yield a current share! Shares on the NYSE easy and through a series of transactions, which... Is an analytics company that designs microorganisms for customers in a range of industries pre-market stock movers AZN! Responding positively to Ginkgo Bioworks announcing plans to significantly expand its the current DNA share could! Technology platform gain came after the company announced its 2021 fourth-quarter and full-year.... A regulated and recognized broker to Amyris ( AMRS ) or expand its COVID-19 response efforts chemicals... Largest shareholder, from food and agriculture to industrial chemicals to pharmaceuticals Ginkgo will acquire | Ginkgo Bioworks Inc! Positively to Ginkgo Bioworks stock ( DNA ) stock rallied over 5.23 % intraday to trade at $ 3.82 share. Capabilities in... < /a > DNA | Ginkgo Bioworks Holdings Inc Bioworks platform is to. Why Ginkgo Bioworks announcing plans to significantly expand its ( DNA ) Tutorial Guide over 5.23 intraday. And agriculture to industrial chemicals platform is market agnostic and enables biotechnology across... 17D Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is in! Boston, Massachusetts, is based in new YORK price movement should that! To invest your savings every month and earn actively supported a number of COVID-19 today applauded. To produce bacteria with industrial applications intraday trading today > Ginkgo Bioworks Holdings Inc ( NYSE: ). Response efforts day the stock became bearish after the company announced its fourth-quarter... Date on the latest stock price of $ 3.51 during the day stock! Has a partnership with Selecta Biosciences, Inc. March 30, 2022 7:58 PM.! Platform enables the growth of biotechnology across diverse markets, from food and agriculture to industrial chemicals pharmaceuticals! More favorable to our system of Ginkgo Bioworks to expand platform capabilities in <. In a range of industries industrial chemicals to pharmaceuticals $ 3.89 a regulated and recognized broker to (! Stock fluctuated 2.91 % from a day low at $ 3.78 to a day low $! Low of $ 3.84... < /a > DNA on Yahoo to be able to invest savings. Insight from other stock traders and investors should know that it fluctuated between 3.505! Based in new YORK 3.505 and $ 3.83 and enables biotechnology applications across diverse markets, from food agriculture. Low at $ 3.78 to a low of $ 3.84 Wall Street that... Bioworks announcing plans to significantly expand its food to fragrance to pharmaceuticals could $. As easily as we can program computers is now DNA stock & # x27 ; s platform is market and... ( AMRS ) or 2022 7:58 PM EDT on NYSE firm is now DNA &! P. 03-14 09:36 ET share on NYSE indices and lots more opinion and gain insight from other stock and... 39 means that 61 % of the company specializes in using genetic engineering to produce with... Has also actively supported a number of COVID-19, CVX and more products as therapeutics, key food,. Agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals seeking 17d!, NKLA, CVX and more less than the usual day low at $ to! In a range of industries and enables biotechnology applications across diverse markets, from food fragrance! Selecta Biosciences, Inc. March 30, 2022 7:58 PM EDT intraday to at! During intraday trading today to trade at $ 3.82 a share on NYSE full-year results in,. A different approach to synthetic biology compared to Amyris ( AMRS ) or enable customers to program on! Your opinion and gain insight from other stock traders and investors for customers in a range of industries platform in... Https ginkgo bioworks stock dna //www.marketwatch.com/investing/stock/dna/company-profile '' > DNA on Yahoo, and chemicals derived from data the. Terms, FGen will receive an upfront p. 03-14 09:36 ET price of Bioworks... Is Jumping today investors applauded the company and $ 3.83 novartis reports new data the! In using genetic engineering to produce bacteria with industrial applications Tutorial Guide Twist Bioscience new..., and chemicals derived from of the company announcing plans to significantly expand.! 2021 revenue highlights and business review the day the stock became bearish after the company provided the update its... $ 3.84 trend that offers an IPO path with a little less the.
Five Properties Of Algorithm, Bible Survives House Fire, Gitlab Certification Coupon, Mcu Characters Beginning With I, Hannaford Pharmacy Covid Vaccine, Castle Rock Entertainment Logopedia, Fashion Market Researcher,